Targeted‐nanoliposomal combretastatin A4 (CA‐4) as an efficient antivascular candidate in the metastatic cancer treatment-Reference-Cited by-同舟云学术

Targeted‐nanoliposomal combretastatin A4 (CA‐4) as an efficient antivascular candidate in the metastatic cancer treatment

Published:2019-01-29 Issue:9 Volume:234 Page:14721-14733
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Nik Maryam Ebrahimi¹²,Momtazi‐Borojeni Amir Abbas¹³^ORCID,Zamani Parvin¹³,Navashenaq Jamshid Gholizadeh²⁴,Iranshahi Mehrdad⁵,Jaafari Mahmoud Reza⁵⁶^ORCID,Malaekeh‐Nikouei Bizhan¹^ORCID

Affiliation:

1. Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

2. Student Research Committee, Mashhad University of Medical Sciences Mashhad Iran

3. Department of Medical Biotechnology Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

4. Department of Immunogenetic and Cell Culture Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences Mashhad Iran

5. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

6. Department of Pharmaceutical Nanotechnology School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28230

Reference100 articles.

1. Nanoparticle Technologies for Cancer Therapy

2. Drug Delivery Systems: Entering the Mainstream

3. Curcumin improved liposomal mitomycin‐induced cell toxicity in bladder cancer cell;Amanolahi F.;Nanomedicine Journal,2018

4. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas

5. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis;Current Medicinal Chemistry;2024-09

2. In vitro results with minimal blood toxicity of a combretastatin A4 analogue;Investigational New Drugs;2024-05-17

3. Enhancing anti-angiogenic immunotherapy for melanoma through injectable metal–organic framework hydrogel co-delivery of combretastatin A4 and poly(I:C);Nanoscale Advances;2024

4. Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles;Scientific Reports;2023-10-21

5. Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: in-vitro study;Medical Oncology;2023-10-14